These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1964393)

  • 41. Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors.
    Wang WJ; Tai CK; Kasahara N; Chen TC
    Hum Gene Ther; 2003 Jan; 14(2):117-27. PubMed ID: 12614563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective transduction of HIV-1-infected cells by the combination of HIV and MMLV vectors.
    Sakai N; Miyake K; Suzuki N; Shimada T
    Int J Hematol; 2001 Jun; 73(4):476-482. PubMed ID: 11503962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.
    Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N
    Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.
    DePolo NJ; Harkleroad CE; Bodner M; Watt AT; Anderson CG; Greengard JS; Murthy KK; Dubensky TW; Jolly DJ
    J Virol; 1999 Aug; 73(8):6708-14. PubMed ID: 10400768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
    Patience C; Takeuchi Y; Cosset FL; Weiss RA
    J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tumor gene therapy.
    Cirielli C; Capogrossi MC; Passaniti A
    J Neurooncol; 1997 Jan; 31(1-2):217-23. PubMed ID: 9049851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaceutical approach to somatic gene therapy.
    Ledley FD
    Pharm Res; 1996 Nov; 13(11):1595-614. PubMed ID: 8956323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
    Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D
    Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retroviral vectors. From laboratory tools to molecular medicine.
    Vile RG; Tuszynski A; Castleden S
    Mol Biotechnol; 1996 Apr; 5(2):139-58. PubMed ID: 8734426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer.
    Purcell DF; Broscius CM; Vanin EF; Buckler CE; Nienhuis AW; Martin MA
    J Virol; 1996 Feb; 70(2):887-97. PubMed ID: 8551628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice.
    Cornetta K; Moore A; Johannessohn M; Sledge GW
    Clin Exp Metastasis; 1994 Jan; 12(1):3-12. PubMed ID: 8287617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis.
    Vanin EF; Kaloss M; Broscius C; Nienhuis AW
    J Virol; 1994 Jul; 68(7):4241-50. PubMed ID: 8207799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.
    Rother RP; Fodor WL; Springhorn JP; Birks CW; Setter E; Sandrin MS; Squinto SP; Rollins SA
    J Exp Med; 1995 Nov; 182(5):1345-55. PubMed ID: 7595205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement-protected amphotropic retroviruses from murine packaging cells.
    Spitzer D; Hauser H; Wirth D
    Hum Gene Ther; 1999 Jul; 10(11):1893-902. PubMed ID: 10446929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Replication of enhancer-deficient amphotropic murine leukemia virus in human fibrosarcoma but not in primary human fibroblasts.
    Reuss FU; Berdel B; Heber R; Bantel-Schaal U
    J Med Virol; 2002 Oct; 68(2):278-84. PubMed ID: 12210420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
    Traister RS; Lynch WP
    Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates.
    Cornetta K; Moen RC; Culver K; Morgan RA; McLachlin JR; Sturm S; Selegue J; London W; Blaese RM; Anderson WF
    Hum Gene Ther; 1990; 1(1):15-30. PubMed ID: 1964393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus.
    Cornetta K; Morgan RA; Gillio A; Sturm S; Baltrucki L; O'Reilly R; Anderson WF
    Hum Gene Ther; 1991; 2(3):215-9. PubMed ID: 1661171
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.